Kathmere Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $634K | Buy |
3,415
+91
| +3% | +$16.9K | 0.05% | 236 |
|
|
2025
Q1 | $696K | Buy |
3,324
+428
| +15% | +$89.7K | 0.06% | 188 |
|
|
2024
Q4 | $515K | Buy |
2,896
+400
| +16% | +$71.1K | 0.05% | 219 |
|
|
2024
Q3 | $493K | Buy |
2,496
+775
| +45% | +$153K | 0.05% | 207 |
|
|
2024
Q2 | $295K | Sell |
1,721
-548
| -24% | -$94K | 0.03% | 260 |
|
|
2024
Q1 | $413K | Buy |
2,269
+71
| +3% | +$12.9K | 0.05% | 187 |
|
|
2023
Q4 | $341K | Sell |
2,198
-801
| -27% | -$124K | 0.04% | 186 |
|
|
2023
Q3 | $447K | Buy |
2,999
+392
| +15% | +$58.4K | 0.07% | 135 |
|
|
2023
Q2 | $351K | Sell |
2,607
-1,011
| -28% | -$136K | 0.05% | 144 |
|
|
2023
Q1 | $577K | Buy |
3,618
+563
| +18% | +$89.7K | 0.09% | 105 |
|
|
2022
Q4 | $494K | Buy |
3,055
+784
| +35% | +$127K | 0.09% | 100 |
|
|
2022
Q3 | $305K | Buy |
2,271
+55
| +2% | +$7.39K | 0.06% | 121 |
|
|
2022
Q2 | $339K | Buy |
2,216
+65
| +3% | +$9.94K | 0.06% | 105 |
|
|
2022
Q1 | $349K | Buy |
2,151
+488
| +29% | +$79.2K | 0.06% | 110 |
|
|
2021
Q4 | $225K | Buy |
+1,663
| New | +$225K | 0.04% | 126 |
|
|
2021
Q1 | – | Sell |
-1,411
| Closed | -$151K | – | 135 |
|
|
2020
Q4 | $151K | Buy |
1,411
+200
| +17% | +$21.4K | 0.03% | 148 |
|
|
2020
Q3 | $106K | Buy |
+1,211
| New | +$106K | 0.03% | 173 |
|
|
2020
Q1 | – | Sell |
-2,895
| Closed | -$256K | – | 81 |
|
|
2019
Q4 | $256K | Buy |
+2,895
| New | +$256K | 0.09% | 86 |
|